| Mrs Thelma Reyne Berland, MS CCC-SLP | |
|
1260 2 Rd, Damar, KS 67632-9208 | |
| (785) 839-4266 | |
| Not Available |
| Full Name | Mrs Thelma Reyne Berland |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1260 2 Rd, Damar, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457561185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1416 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Thelma Reyne Berland, MS CCC-SLP 1260 2 Rd, Damar, KS 67632-9208 Ph: (785) 839-4266 | Mrs Thelma Reyne Berland, MS CCC-SLP 1260 2 Rd, Damar, KS 67632-9208 Ph: (785) 839-4266 |
News Archive
Laboratoires Thea, the leading independent ophthalmic group in Europe, completes its innovative product range with the announcement of the final acquisition of Mydriasert(R). Mydriasert(R), the 1st mydriatic ophthalmic insert, is indicated for dilated fundus examination (DFE) or cataract surgery, the most widely implemented surgical procedure. Regarding cataract surgery, the market represents close to 300 000 procedures in the UK and Ireland and 3 million in Europe each year.
Genentech Inc., now part of Swiss drug developer Roche, and Biogen Idec Inc. on Sunday have announced positive and encouraging results from a clinical study of cancer drug Rituxan in patients with advanced type of non-Hodgkin's lymphoma. An estimated 65,540 people in the US were diagnosed with non-Hodgkin's lymphoma this year, and follicular lymphoma accounts for about 15 to 20 percent of those cases. The disease can occur at any time during adulthood, though people are typically diagnosed during their 50s and 60s.
A top legislative priority of the Lupus Research Institute (LRI) - funding for a nationwide lupus education effort for healthcare providers - is included in the Fiscal 2012 omnibus appropriations bill (H.R. 2055) signed into law today by President Obama after passing in the House of Representatives and the Senate.
In children, primary spinal tumors comprise 4% of all tumors from the central nervous system. Spinal tumors can present with a variety of clinical signs and symptoms in children such as pain followed by motor regression, gait disturbance, sphincter dysfunction, sensory symptoms, torticollis, and kyphoscoliosis.
› Verified 1 days ago